0001562180-21-000307.txt : 20210112 0001562180-21-000307.hdr.sgml : 20210112 20210112164838 ACCESSION NUMBER: 0001562180-21-000307 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210108 FILED AS OF DATE: 20210112 DATE AS OF CHANGE: 20210112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christmas Patrick J. CENTRAL INDEX KEY: 0001521123 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37553 FILM NUMBER: 21524021 MAIL ADDRESS: STREET 1: C/O REGENXBIO INC. STREET 2: 9600 BLACKWELL ROAD, SUITE 210 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENXBIO Inc. CENTRAL INDEX KEY: 0001590877 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471851754 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9600 BLACKWELL ROAD STREET 2: SUITE 210 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-552-8181 MAIL ADDRESS: STREET 1: 9600 BLACKWELL ROAD STREET 2: SUITE 210 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: REGENXBIO, Inc. DATE OF NAME CHANGE: 20150116 FORMER COMPANY: FORMER CONFORMED NAME: ReGenX Biosciences, LLC DATE OF NAME CHANGE: 20131101 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-01-08 false 0001590877 REGENXBIO Inc. RGNX 0001521123 Christmas Patrick J. C/O REGENXBIO INC. 9600 BLACKWELL ROAD, SUITE 210 ROCKVILLE MD 20850 false true false false Chief Legal Officer Common Stock 2021-01-08 4 M false 10000.00 12.10 A 26372.00 D Common Stock 2021-01-08 4 S false 4618.00 46.43 D 21754.00 D Common Stock 2021-01-08 4 S false 4062.00 47.42 D 17692.00 D Common Stock 2021-01-08 4 S false 1320.00 48.13 D 16372.00 D Common Stock 2021-01-11 4 M false 7500.00 12.10 A 23872.00 D Common Stock 2021-01-11 4 M false 2622.00 19.50 A 26494.00 D Common Stock 2021-01-11 4 S false 10122.00 49.08 D 16372.00 D Common Stock 2021-01-12 4 M false 1378.00 19.50 A 17750.00 D Common Stock 2021-01-12 4 S false 1378.00 49.15 D 16372.00 D Employee Stock Option (Right to Buy) 12.10 2021-01-08 4 M false 10000.00 0.00 D 2026-08-17 Common Stock 10000.00 29931.00 D Employee Stock Option (Right to Buy) 12.10 2021-01-11 4 M false 7500.00 0.00 D 2026-08-17 Common Stock 7500.00 22431.00 D Stock Option (Right to Buy) 19.50 2021-01-11 4 M false 2622.00 0.00 D 2027-01-03 Common Stock 2622.00 2019.00 D Stock Option (Right to Buy) 19.50 2021-01-12 4 M false 1378.00 0.00 D 2027-01-03 Common Stock 1378.00 641.00 D This transaction was effected pursuant to a Rule 10b5-1 trading plan. This transaction was executed in multiple trades at prices ranging from $45.86 to $46.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $46.87 to $47.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $47.87 to $48.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $49.00 to $49.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $49.00 to $49.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The previously granted option, representing a right to purchase a total of 125,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 18, 2017, and the balance vested in equal monthly installments over the 36 months thereafter. The previously granted option, representing a right to purchase a total of 11,100 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vested in equal monthly installments over the 36 months thereafter. /s/ Patrick J. Christmas 2021-01-12